You can count on our end-to-end dermatology expertise to optimize the management of your clinical programs. We allocate resources, teams and technologies to support your projects in a way that optimizes quality, timelines, outcomes and ultimately enhances your studies' probability of success. In short, we leverage our 20+ years of dermatology clinical research experience to assist you in your journey to treatment discovery.
No matter how complex your study is, our all-inclusive services will help you achieve a streamlined clinical development for your phase 2b – 3 studies.
Our dermatology experts proactively evaluate protocol and recruitment objectives to successfully address challenges surrounding late-phase trials, namely stringent regulatory requirements, patient and site recruitment challenges, complex protocol designs and procedures, and patient-reported outcomes.
Our problem-solving approach is designed to help you manage costs and mitigate risks that are inherent to your clinical projects.
With moving parts such as study design, regulatory requirements and clinical project optimization, early-phase clinical research is a constantly changing endeavour. Our team of dermatology experts can support your early development programs to efficiently reach relevant data milestones, both for topical and systemic compounds.
We manage phase I, Proof of Concept (POC) and First-in-Man (FIM) studies as a single center or multicenter studies where we can leverage our own Clinical Research Unit for operational synergies.
Innovaderm strictly operates in accordance with Standard Operating Procedures (SOPs) to meet current Good Clinical Practice (GCP) from the International Conference of Harmonization (ICH) and is fully compliant with major international regulations such as the FDA (USA), Health Canada and EMA (Europe).
